NCT04529850 2022-08-16Ph 2 Open Label Study of GC4419 to Reduce SOM Associated With Chemoradiotherapy for Head and Neck CancerGalera Therapeutics, Inc.Phase 2 Completed38 enrolled 10 charts
NCT00267046 2012-05-16Evaluate PKs and Efficacy Assessment of Palifermin in Patients With SarcomaM.D. Anderson Cancer CenterPhase 2 Completed49 enrolled 7 charts